For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
ILLUSTRATION BY ERIN MOORE
ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009
*HER2 is also associated with breast cancer.
Related Content:
Therapies Which Received FDA Approval in July: What Patients Should Know
A Cocktail and the Freedom I Never Expected With Cancer
Leronlimab Shows Activity in Advanced Metastatic Colorectal Cancer
The Utility of CAR T-Cell Therapy in Myelofibrosis
